Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chin B Eap

Showing results (101-110 of 179) with videos related to

Pageof 18
Sort By:
Expert Opinion on Drug Safety|August 21, 2019
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an updateCéline J Fischer Fumeaux, Mathilde Morisod Harari, Etienne Weisskopf, et al.
Pharmacogenetics and Genomics|September 26, 2017
Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugsAurélie Delacrétaz, Patricia Lagares Santos, Nuria Saigi Morgui, et al.
Clinical Epigenetics|December 28, 2019
Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patientsAurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Journal of Clinical Psychopharmacology|March 23, 2002
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizersStefan Begré, Ulrich von Bardeleben, Dieter Ladewig, et al.
Archives of Internal Medicine|March 24, 2010
Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc intervalNicolas Ansermot, Ozgür Albayrak, Jürg Schläpfer, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatmentSéverine Crettol, Jean-Jacques Déglon, Jacques Besson, et al.
The Journal of Clinical Psychiatry|April 19, 2019
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset HypercholesterolemiaAurélie Delacrétaz, Frederik Vandenberghe, Anaïs Glatard, et al.
Bjpsych Open|December 5, 2024
Lipid disturbances induced by psychotropic drugs: clinical and genetic predictors for early worsening of lipid levels and new-onset dyslipidaemia in Swiss psychiatric samplesAurélie Delacrétaz, Marie Sadler, Franziska Gamma, et al.
Journal of Clinical Psychopharmacology|April 24, 2013
Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effectsEva Choong, Andrea Polari, Rigobert Hervais Kamdem, et al.
British Journal of Clinical Pharmacology|July 23, 2016
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled studyValentina Forni Ogna, Isabelle Menetrey, Olivier Muller, et al.
Pageof 18

Showing results (101-110 of 179) with videos related to

Sort By:
Pageof 18
Expert Opinion on Drug Safety|August 21, 2019
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence - an updateCéline J Fischer Fumeaux, Mathilde Morisod Harari, Etienne Weisskopf, et al.
Pharmacogenetics and Genomics|September 26, 2017
Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugsAurélie Delacrétaz, Patricia Lagares Santos, Nuria Saigi Morgui, et al.
Clinical Epigenetics|December 28, 2019
Psychotropic drug-induced genetic-epigenetic modulation of CRTC1 gene is associated with early weight gain in a prospective study of psychiatric patientsAurélie Delacrétaz, Anaïs Glatard, Céline Dubath, et al.
Journal of Clinical Psychopharmacology|March 23, 2002
Paroxetine increases steady-state concentrations of (R)-methadone in CYP2D6 extensive but not poor metabolizersStefan Begré, Ulrich von Bardeleben, Dieter Ladewig, et al.
Archives of Internal Medicine|March 24, 2010
Substitution of (R,S)-methadone by (R)-methadone: Impact on QTc intervalNicolas Ansermot, Ozgür Albayrak, Jürg Schläpfer, et al.
Clinical Pharmacology and Therapeutics|December 13, 2005
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatmentSéverine Crettol, Jean-Jacques Déglon, Jacques Besson, et al.
The Journal of Clinical Psychiatry|April 19, 2019
Lipid Disturbances in Adolescents Treated With Second-Generation Antipsychotics: Clinical Determinants of Plasma Lipid Worsening and New-Onset HypercholesterolemiaAurélie Delacrétaz, Frederik Vandenberghe, Anaïs Glatard, et al.
Bjpsych Open|December 5, 2024
Lipid disturbances induced by psychotropic drugs: clinical and genetic predictors for early worsening of lipid levels and new-onset dyslipidaemia in Swiss psychiatric samplesAurélie Delacrétaz, Marie Sadler, Franziska Gamma, et al.
Journal of Clinical Psychopharmacology|April 24, 2013
Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effectsEva Choong, Andrea Polari, Rigobert Hervais Kamdem, et al.
British Journal of Clinical Pharmacology|July 23, 2016
Effect of long-term adherence to clopidogrel on the VASP-PRI after elective coronary stent implantation: a randomized controlled studyValentina Forni Ogna, Isabelle Menetrey, Olivier Muller, et al.
Pageof 18